Results 21 to 30 of about 4,155 (158)

Updated ACR guidelines for the management of axial spondylitis

Научно-практическая ревматология, 2020
The paper provides the updated American College of Rheumatology (ACR) guidelines for the treatment of ankylosing spondylitis and non-radiographic axial spondyloarthritis.
Sh. Erdes
doaj   +1 more source

Clinical characteristics of non‐radiographic axial spondyloarthritis: Results of the Korean Nonradiographic Axial SPondyloArthritis (KONASPA) data

International Journal of Rheumatic Diseases, 2021
AbstractAimTo evaluate clinical characteristics and natural history of non‐radiographic axial spondyloarthritis (nr‐axSpA) using KOrean Nonradiographic Axial SPondyloArthritis (KONASPA) data.MethodsData were collected from 11 centers in South Korea. A total of 278 patients with nr‐axSpA from January 2018 to July 2020 were included.
Hyemin Jeong, Yong‐Gil Kim, Tae‐Hwan Kim, Tae‐Jong Kim, Min‐Chan Park, Mi Ryoung Seo, Kichul Shin, Ji Seon Oh, Sang‐Hoon Lee, Yeon‐Ah Lee, Eun Young Lee, Han Joo Baek, Hoon‐Suk Cha   +12 more
openaire   +3 more sources

Relationship between disease activity status or clinical response and patient-reported outcomes in patients with non-radiographic axial spondyloarthritis: 104-week results from the randomized controlled EMBARK study

Health and Quality of Life Outcomes, 2020
Background We assessed the external validity of composite indices Ankylosing Spondylitis Disease Activity Score (ASDAS), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and Assessment in SpondyloArthritis international Society (ASAS) 40 ...
Maxime Dougados, Désirée van der Heijde, Wen-Chan Tsai, Diego Saaibi, Lisa Marshall, Heather Jones, Ron Pedersen, Bonnie Vlahos, Miriam Tarallo   +8 more
doaj   +1 more source

A single center experience: physician related diagnostic delay and demographic and clinical differences between patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis

Romanian Journal of Internal Medicine, 2021
Background. A large number of comparative studies have been conducted for ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA), including disease burden, treatment modalities and patient characteristics.
Ulutaş Firdevs, Çobankara Veli, Şenol Hande, Karasu Uğur, Kaymaz Serdar, Yaşar Canan Albayrak, Ök Zeynep Dündar, Yiğit Murat   +7 more
doaj   +1 more source

Axial spondyloarthritis: a current look at the concept and evolution of the disease

Современная ревматология, 2019
The article provides data on the terminology and classification of spondyloarthritis (SpA) and highlights the current concept of axial SpA (axSpA). It gives the comparative characteristics of international cohorts of patients with axSpA.
D. G. Rumyantseva, Sh. F. Erdes
doaj   +1 more source

The first non‐radiographic axial spondyloarthrits with COVID‐19

Immunity, Inflammation and Disease, 2021
Background Case report of a 21‐year‐old female developing non‐radiographic axialspondyloarthritis in the setting of a preceding severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection.
Wassim Saikali, Suzanne Gharib
doaj   +1 more source

Etanercept in axial spondyloarthritis – treatment efficacy

Научно-практическая ревматология, 2022
The beginning of the 21st century was marked by a simultaneous changes in view on pathogenesis, diagnostics and treatment of axial spondyloarthritis (axSpA). Anti-TNFα inhibitors were the first biologics prescribed in axSpA.
I. Z. Gaydukova, O. V. Inamova, R. R. Samigullina, A. L. Chudinov, A. S. Bychkova   +4 more
doaj   +1 more source

Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis

Frontiers in Immunology, 2021
The IL-23/IL-17 pathway has been implicated in the etiopathogenesis of axial spondyloarthritis through studies of genetic polymorphisms associated with disease, an animal model with over-expression of IL-23 that resembles human disease, and observations ...
Runsheng Wang, Runsheng Wang, Walter P. Maksymowych, Walter P. Maksymowych   +3 more
doaj   +1 more source

Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum

Frontiers in Medicine, 2023
BackgroundSecukinumab is a biologic disease-modifying antirheumatic drug (bDMARD) that has demonstrated efficacy in the treatment of axial spondyloarthritis (axSpA, i.e., ankylosing spondylitis and non-radiographic axSpA) across various clinical trials ...
Francisca Sivera, Francisca Sivera, Victoria Núñez-Monje, Cristina Campos-Fernández, Isabel Balaguer-Trull, Montserrat Robustillo-Villarino, Marta Aguilar-Zamora, Marta Garijo-Bufort, Juan Miguel López-Gómez, Carolina Peña-González, Isabel de la Morena, Diego Bedoya-Sanchís, Liliya Yankova-Komsalova, Arantxa Conesa-Mateos, Anna Martínez-Cristóbal, Francisco Javier Navarro-Blasco, José Miguel Senabre-Gallego, Juan José Alegre-Sancho   +17 more
doaj   +1 more source

Comparison of osteoporosis frequency in female patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis

Ulusal Romatoloji Dergisi
Objective: The aim of this study is to determine of the frequency of osteoporosis in patient with non-radiographic axial spondyloarthritis (SpA) and ankylosing spondilitis.
Bekir Torun, Şükran Erten
doaj   +1 more source